Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Forxiga in type 2 diabetes mellitus (France, CHU de Dijon)
2015-005034-21Phase 4Active
- Sponsor
- Centre Hospitalier Universitaire Dijon Bourgogne
- Start
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dapagliflozin in type 2 diabetes mellitus (T2DM), sponsored by Centre Hospitalier Universitaire Dijon Bourgogne. Started Dec 2015; status: active.
02
Drugs
dapagliflozin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2015-005034-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005034-21.